VivoPower Provides Further Updates with Respect to Non-Binding US$180 Million Takeover Proposal and Business Unit Spin-Offs

Stock Information for AnPac Bio-Medical Science Co. Ltd.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About AnPac Bio-Medical Science Co. Ltd.

VivoPower Advances US$180 Million Non-Binding Takeover with Successful Completion of First Phase of Due Diligence
Vivopower's Tembo Secures Definitive Order from The Safari Collection in Africa
VivoPower provides clarification re US$180 million enterprise value takeover proposal
VivoPower's Tembo Signs Definitive Distribution Agreement with the Kingdom of Saudi Arabia's Green Watt Worth up to an Estimated US$85 Million over 5 Years
VivoPower Confirms Continuation of Proposed US$180 Million Takeover Process: US Tariffs Not Expected to Affect Tembo Business
VivoPower Provides Update on Non-Binding Takeover Offer at Enterprise Value of US$180 Million and Tembo Business Combination Agreement at Combined Enterprise Value of US$904 Million
VivoPower Agrees to Grant Exclusivity to Energi Subject to Increase in Non-Binding All-Cash Takeover Offer to Enterprise Value of US$180 Million
VivoPower in Advanced Bilateral Negotiations on All-Cash Takeover Offer at Enterprise Value of US$120 Million

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.